Ligand validation:5GTO

MYR: MYRISTIC ACID

MYR is a Ligand Of Interest in 5GTO designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5GTO_MYR_A_502	0%	45%	0.631	0.587	0.83	1.27	1	3	1	0	100%	1
3SZ1_MYR_B_478	13%	47%	0.305	0.847	0.96	1.1	1	2	2	0	100%	1
5GTP_MYR_A_501	0%	42%	0.717	0.711	0.43	1.78	-	3	2	0	100%	1
8Q2Z_MYR_C_201	93%	68%	0.081	0.975	0.46	0.77	-	-	0	0	100%	0.9375
6NOK_MYR_A_401	92%	52%	0.077	0.967	0.71	1.14	-	2	0	0	100%	1
8Q3D_MYR_D_101	92%	65%	0.086	0.975	0.53	0.81	-	-	0	0	100%	0.9375
7OWO_MYR_D_401	88%	73%	0.088	0.962	0.45	0.59	-	-	0	0	100%	0.525
8Q3T_MYR_C_201	87%	69%	0.092	0.965	0.47	0.72	-	-	0	0	100%	0.9375

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.